Results 211 to 220 of about 129,727 (305)
ABSTRACT Body mass index (BMI) on its own is a poor diagnostic and staging tool for obesity because it does not measure health status. The newly published Lancet Clinical Obesity Criteria (LCOC) for defining clinical obesity distinguish preclinical and clinical obesity based on organ or tissue dysfunction.
Tak Ying Louise Ko +3 more
wiley +1 more source
Adiponectin gene polymorphisms rs1501299 and rs17300539 are not associated with polycystic ovary syndrome. [PDF]
Taşkin E, Eroğlu S.
europepmc +1 more source
ABSTRACT Overweight and obesity are estimated to affect more than 40% of adults in the Asia‐Pacific (APAC) region. This study used a cross‐sectional online survey to assess the impact of obesity on health‐related quality of life (HRQOL) using the Impact of Weight on Quality of Life (IWQOL)‐Lite instrument and willingness to pay for obesity management ...
Hae‐Jin Ko +5 more
wiley +1 more source
Pathogenesis and treatment of obesity-related polycystic ovary syndrome. [PDF]
Ouyang X, Zhou Q, Tang H, Li L.
europepmc +1 more source
A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease [PDF]
Allolio, B. +4 more
core +1 more source
Abstract Aims To evaluate the impact of obesity, with or without gestational diabetes mellitus (GDM), on adverse maternal outcomes and determine whether the combination of obesity and GDM confers a greater risk compared to obesity alone. Methods We systematically searched MEDLINE, EMBASE, Scopus, CINAHL and the WoS Core Collection, identifying 19 ...
Tessa L. Weir +2 more
wiley +1 more source
Bariatric surgery as a treatment of polycystic ovary syndrome: a systematic review and meta-analysis. [PDF]
Mirghani H, Shaman A.
europepmc +1 more source
Drospirenone/Ethinyl EstradiolVersusRosiglitazone Treatment in Overweight Adolescents with Polycystic Ovary Syndrome: Comparison of Metabolic, Hormonal, and Cardiovascular Risk Factors [PDF]
Hala Tfayli +4 more
openalex +1 more source

